Published in Law and Health Weekly, June 9th, 2007
"The KaLy-Cell partnership is an entry point into new, life science-based markets for Diagnostic HYBRIDS and takes advantage of our current manufacturing infrastructure and technical expertise in cell-based technologies," said David Scholl, Ph.D., company...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.